Involvement of proapoptotic Bcl-2 family members in terbinafine-induced mitochondrial dysfunction and apoptosis in HL60 cells

Food and Chemical Toxicology

Volumn 44, Issue 2, 2006, Pages 214-226

  Yang, Kuo Ching ^a   Wu, Chi Chen ^b   Wu, Chih Hsiung ^b   Chen, Jur Hao ^a   Chu, Chien Hwa ^c   Chen, Chien Ho ^c   Chou, Yean Hwei ^a   Wang, Ying Jan ^d   Lee, Wen Sen ^b   Tseng, How ^b   Lin, Shyr Yi ^b   Lee, Chia Hwa ^c   Ho, Yuan Soon ^c  

^a Shinkong Wu Ho Su Memorial Hospital   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Apoptosis; Caspase 9; HL60; Mitochondria; Terbinafine

Indexed keywords

BENZYLOXYCARBONYLLEUCYLGLUTAMYLHISTIDYLASPARTYL FLUOROMETHYL KETONE; BIOLOGICAL MARKER; CASPASE 9; CASPASE INHIBITOR; CD11B ANTIGEN; CD33 ANTIGEN; CD95 RECEPTOR; CYTOCHROME C; FAS ANTIGEN; GEMTUZUMAB OZOGAMICIN; PROTEIN BCL 2; RECEPTOR; TERBINAFINE; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRAIN HL 60; CELL SURFACE; CYTOSOL; ELECTROCHEMISTRY; EVALUATION; GENE OVEREXPRESSION; GENETIC TRANSFECTION; GROWTH DISORDER; HUMAN; HUMAN CELL; HYPOTHESIS; IN VITRO STUDY; MEDIATOR; MEMBRANE PERMEABILITY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL TOXICITY; MOLECULAR MECHANICS; MORPHOLOGY; PLASMID; PROTEIN FAMILY; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANTIGENS, CD95; ANTIGENS, SURFACE; APOPTOSIS; BLOTTING, WESTERN; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CELL SURVIVAL; CYTOCHROMES C; CYTOSOL; ENZYME INHIBITORS; FLOW CYTOMETRY; GENES, BCL-2; GENES, P53; HL-60 CELLS; HUMANS; IMMUNOPRECIPITATION; MEMBRANE POTENTIALS; MITOCHONDRIA; NAPHTHALENES; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 28844486322     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2005.07.008     Document Type: Article

References (47)

1. S.M. Abdel-Rahman, and M.C. Nahata Oral terbinafine: a new antifungal agent Ann. Pharmacother. 31 4 1997 445 456
2. H. Ashktorab, S. Frank, A.R. Khaled, S.K. Durum, B. Kifle, and D.T. Smoot Bax translocation and mitochondrial fragmentation induced by Helicobacter pylori Gut 53 6 2004 805 813
3. B.C. Barnhart, E.M. Pietras, A. Algeciras-Schimnich, L. Salmena, K. Sayama, R. Hakem, and M.E. Peter CD95 apoptosis resistance in certain cells can be overcome by noncanonical activation of caspase-8 Cell Death Differ. 12 1 2005 25 37
4. S. Bergeron, M. Beauchemin, and R. Bertrand Camptothecin- and etoposide-induced apoptosis in human leukemia cells is independent of cell death receptor-3 and -4 aggregation but accelerates tumor necrosis factor-related apoptosis-inducing ligand-mediated cell death Mol. Cancer Ther. 3 12 2004 1659 1669
5. C. Borner The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions Mol. Immunol. 39 11 2003 615 647
6. H. Caceres-Rios, M. Rueda, R. Ballona, and B. Bustamante Comparison of terbinafine and griseofulvin in the treatment of tinea capitis J. Am. Acad. Dermatol. 42 1 Pt 1 2000 80 84
7. R.J. Chen, W.S. Lee, Y.C. Liang, J.K. Lin, Y.J. Wang, C.H. Lin, J.Y. Hsieh, C.C. Chaing, and Y.S. Ho Ketoconazole induces G0/G1 arrest in human colorectal and hepatocellular carcinoma cell lines Toxicol. Appl. Pharmacol. 169 2 2000 132 141
8. A.K. Gupta, and N.H. Shear Terbinafine: an update J. Am. Acad. Dermatol. 37 6 1997 979 988
9. K.M. Hajra, and J.R. Liu Apoptosome dysfunction in human cancer Apoptosis 9 6 2004 691 704
10. J.Y. Han, E.K. Hong, B.G. Choi, J.N. Park, K.W. Kim, J.H. Kang, J.Y. Jin, S.Y. Park, Y.S. Hong, and K.S. Lee Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small-cell lung cancer Med. Oncol. 20 4 2003 355 362
11. Y.S. Ho, Y.J. Wang, and J.K. Lin Induction of p53 and p21/WAF1/CIP1 expression by nitric oxide and their association with apoptosis in human cancer cells Mol. Carcinog. 16 1 1996 20 31
12. Y.S. Ho, P.W. Tsai, C.F. Yu, H.L. Liu, R.J. Chen, and J.K. Lin Ketoconazole-induced apoptosis through P53-dependent pathway in human colorectal and hepatocellular carcinoma cell lines Toxicol. Appl. Pharmacol. 153 1 1998 39 47
13. Y.S. Ho, J.S. Duh, J.H. Jeng, Y.J. Wang, Y.C. Liang, C.H. Lin, C.J. Tseng, C.F. Yu, R.J. Chen, and J.K. Lin Griseofulvin potentiates antitumorigenesis effects of nocodazole through induction of apoptosis and G2/M cell cycle arrest in human colorectal cancer cells Int. J. Cancer 91 3 2001 393 401
14. Y.S. Ho, H.Y. Ma, H.Y. Chang, B.L. Wei, C.C. Lee, S.Y. Ho, H.R. Guo, T.P. Wu, W.H. Chang, and Y.J. Wang Lipid peroxidation and cell death mechanisms in rats and human cells induced by chloral hydrate Food Chem. Toxicol. 41 5 2003 621 629
15. P.Y. Ho, Y.C. Liang, Y.S. Ho, C.T. Chen, and W.S. Lee Inhibition of human vascular endothelial cells proliferation by terbinafine Int. J. Cancer 111 1 2004 51 59
16. H. Humbert, M.D. Cabiac, J. Denouel, and S. Kirkesseli Pharmacokinetics of terbinafine and of its five main metabolites in plasma and urine, following a single oral dose in healthy subjects Biopharm. Drug Dispos. 16 8 1995 685 694
17. J.C. Jensen Clinical pharmacokinetics of terbinafine (Lamisil) Clin. Exp. Dermatol. 14 2 1989 110 113
18. P.K. Kim, R. Mahidhara, and D.W. Seol The role of caspase-8 in resistance to cancer chemotherapy Drug Resist. Updates 4 5 2001 293 296
19. J.M. Kovarik, S. Kirkesseli, H. Humbert, P. Grass, and K. Kutz Dose-proportional pharmacokinetics of terbinafine and its N-demethylated metabolite in healthy volunteers Br. J. Dermatol. 126 Suppl. 39 1992 8 13
20. J.M. Kovarik, E.A. Mueller, H. Zehender, J. Denouel, H. Caplain, and L. Millerioux Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites Antimicrob. Agents Chemother. 39 12 1995 2738 2741
21. S. Lacour, A. Hammann, S. Grazide, D. Lagadic-Gossmann, A. Athias, O. Sergent, G. Laurent, P. Gambert, E. Solary, and M.T. Dimanche-Boitrel Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells Cancer Res. 64 10 2004 3593 3598
22. W.S. Lee, R.J. Chen, Y.J. Wang, H. Tseng, J.H. Jeng, S.Y. Lin, Y.C. Liang, C.H. Chen, C.H. Lin, J.K. Lin, P.Y. Ho, J.S. Chu, W.L. Ho, L.C. Chen, and Y.S. Ho In vitro and in vivo studies of the anticancer action of terbinafine in human cancer cell lines: G0/G1 p53-associated cell cycle arrest Int. J. Cancer 106 1 2003 125 137
23. S.Y. Lin, Y.T. Chang, J.D. Liu, C.H. Yu, Y.S. Ho, Y.H. Lee, and W.S. Lee Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells Mol. Carcinog. 32 2 2001 73 83
24. W.J. Mackus, S.M. Lens, R.H. Medema, M.J. Kwakkenbos, L.M. Evers, M.H. Oers, R.A. Lier, and E. Eldering Prevention of B cell antigen receptor-induced apoptosis by ligation of CD40 occurs downstream of cell cycle regulation Int. Immunol. 14 9 2002 973 982
25. N.A. Maianski, J. Geissler, S.M. Srinivasula, E.S. Alnemri, D. Roos, and T.W. Kuijpers Functional characterization of mitochondria in neutrophils: a role restricted to apoptosis Cell Death Differ. 11 2 2004 143 153
26. N.A. Maianski, D. Roos, and T.W. Kuijpers Bid truncation, bid/bax targeting to the mitochondria, and caspase activation associated with neutrophil apoptosis are inhibited by granulocyte colony-stimulating factor J. Immunol. 172 11 2004 7024 7030
27. S.J. Martin, J.G. Bradley, and T.G. Cotter HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis Clin. Exp. Immunol. 79 3 1990 448 453
28. A.G. Martin, J. Nguyen, J.A. Wells, and H.O. Fearnhead Apo cytochrome c inhibits caspases by preventing apoptosome formation Biochem. Biophys. Res. Commun. 319 3 2004 944 950
29. D. Mezzanzanica, E. Balladore, F. Turatti, E. Luison, P. Alberti, M. Bagnoli, M. Figini, A. Mazzoni, F. Raspagliesi, M. Oggionni, S. Pilotti, and S. Canevari CD95-mediated apoptosis is impaired at receptor level by cellular FLICE-inhibitory protein (long form) in wild-type p53 human ovarian carcinoma Clin. Cancer Res. 10 15 2004 5202 5214
30. A.L. Olins, H. Herrmann, P. Lichter, and D.E. Olins Retinoic acid differentiation of HL-60 cells promotes cytoskeletal polarization Exp. Cell Res. 254 1 2000 130 142
31. E.M. Perchellet, Y. Wang, R.L. Weber, K. Lou, D.H. Hua, and J.P. Perchellet Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling Anticancer Drugs 15 10 2004 929 946
32. G. Petranyi, N.S. Ryder, and A. Stutz Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase Science 224 4654 1984 1239 1241
33. H. Qin, S.M. Srinivasula, G. Wu, T. Fernandes-Alnemri, E.S. Alnemri, and Y. Shi Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1 Nature 399 6736 1999 549 557
34. M. Rademaker, and S. Havill Griseofulvin and terbinafine in the treatment of tinea capitis in children New Zeal. Med. J. 111 1060 1998 55 57
35. J.C. Reed Cytochrome c: can't live with it-can't live without it Cell 91 5 1997 559 562
36. A.M. Rice, J. Li, and A.C. Sartorelli Combination of all-trans retinoic acid and lithium chloride surmounts a retinoid differentiation block induced by expression of Scl and Rbtn2 transcription factors in myeloid leukemia cells Leukemia Res. 28 4 2004 399 403
37. X. Saelens, N. Festjens, L. Vande Walle, M. van Gurp, G. van Loo, and P. Vandenabeele Toxic proteins released from mitochondria in cell death Oncogene 23 16 2004 2861 2874
38. A. Saleh, S.M. Srinivasula, S. Acharya, R. Fishel, and E.S. Alnemri Cytochrome c and dATP-mediated oligomerization of Apaf-1 is a prerequisite for procaspase-9 activation J. Biol. Chem. 274 25 1999 17941 17945
39. Y. Shi Mechanisms of caspase activation and inhibition during apoptosis Mol. Cell 9 3 2002 459 470
40. G. Stabellini, F. Brugnoli, C. Calastrini, L. Vizzotto, M. Vertemati, T. Baroni, E. Caramelli, L. Marinucci, A. Pellati, and V. Bertagnolo Ornithine decarboxylase, polyamines and CD11b expression in HL-60 cells during differentiation induced by retinoic acid Biomed. Pharmacother. 58 6-7 2004 401 406
41. H.R. Stennicke, J.M. Jurgensmeier, H. Shin, Q. Deveraux, B.B. Wolf, X. Yang, Q. Zhou, H.M. Ellerby, L.M. Ellerby, D. Bredesen, D.R. Green, J.C. Reed, C.J. Froelich, and G.S. Salvesen Pro-caspase-3 is a major physiologic target of caspase-8 J. Biol. Chem. 273 42 1998 27084 27090
42. U. Testa Apoptotic mechanisms in the control of erythropoiesis Leukemia 18 7 2004 1176 1199
43. C.J. Tseng, Y.J. Wang, Y.C. Liang, J.H. Jeng, W.S. Lee, J.K. Lin, C.H. Chen, I.C. Liu, and Y.S. Ho Microtubule damaging agents induce apoptosis in HL60 cells and G2/M cell cycle arrest in HT 29 cells Toxicology 175 1-3 2002 123 142
44. J. Wang, Q. Wei, C.Y. Wang, W.D. Hill, D.C. Hess, and Z. Dong Minocycline up-regulates Bcl-2 and protects against cell death in mitochondria J. Biol. Chem. 279 19 2004 19948 19954
45. M.C. Wei, W.X. Zong, E.H. Cheng, T. Lindsten, V. Panoutsakopoulou, A.J. Ross, K.A. Roth, G.R. MacGregor, C.B. Thompson, and S.J. Korsmeyer Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death Science 292 5517 2001 727 730
46. S.H. Woo, I.C. Park, M.J. Park, S. An, H.C. Lee, H.O. Jin, S.A. Park, H. Cho, S.J. Lee, H.S. Gwak, Y.J. Hong, S.I. Hong, and C.H. Rhee Arsenic trioxide sensitizes CD95/Fas-induced apoptosis through ROS-mediated upregulation of CD95/Fas by NF-kappaB activation Int. J. Cancer 112 4 2004 596
47. L. Zhang, and B. Fang Mechanisms of resistance to TRAIL-induced apoptosis in cancer Cancer Gene Ther. 12 3 2005 228 237